Using longitudinal targeted maximum likelihood estimation in complex settings with dynamic interventions
- 22 August 2019
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 38 (24) , 4888-4911
Abstract
Longitudinal targeted maximum likelihood estimation (LTMLE) has very rarely been used to estimate dynamic treatment effects in the context of time‐dependent confounding affected by prior treatment when faced with long follow‐up times, multiple time‐varying confounders, and complex associational relationships simultaneously. Reasons for this include the potential computational burden, technical challenges, restricted modeling options for long follow‐up times, and limited practical guidance in the literature. However, LTMLE has desirable asymptotic properties, ie, it is doubly robust, and can yield valid inference when used in conjunction with machine learning. It also has the advantage of easy‐to‐calculate analytic standard errors in contrast to the g‐formula, which requires bootstrapping. We use a topical and sophisticated question from HIV treatment research to show that LTMLE can be used successfully in complex realistic settings, and we compare results to competing estimators. Our example illustrates the following practical challenges common to many epidemiological studies: (1) long follow‐up time (30 months); (2) gradually declining sample size; (3) limited support for some intervention rules of interest; (4) a high‐dimensional set of potential adjustment variables, increasing both the need and the challenge of integrating appropriate machine learning methods; and (5) consideration of collider bias. Our analyses, as well as simulations, shed new light on the application of LTMLE in complex and realistic settings: We show that (1) LTMLE can yield stable and good estimates, even when confronted with small samples and limited modeling options; (2) machine learning utilized with a small set of simple learners (if more complex ones cannot be fitted) can outperform a single, complex model, which is tailored to incorporate prior clinical knowledge; and (3) performance can vary considerably depending on interventions and their support in the data, and therefore critical quality checks should accompany every LTMLE analysis. We provide guidance for the practical application of LTMLE.Keywords
All Related Versions
Funding Information
- National Institutes of Health (U01AI069924, U01AI069919)
This publication has 50 references indexed in Scilit:
- When to Start Antiretroviral Therapy in Children Aged 2–5 Years: A Collaborative Causal Modelling Analysis of Cohort Studies from Southern AfricaPLOS Medicine, 2013
- A General Implementation of TMLE for Longitudinal Data Applied to Causal Inference in Survival AnalysisThe International Journal of Biostatistics, 2012
- 12-month mortality and loss-to-program in antiretroviral-treated children: The IeDEA pediatric West African Database to evaluate AIDS (pWADA), 2000-2008BMC Public Health, 2011
- The Effect of Highly Active Antiretroviral Therapy on the Survival of HIV-Infected Children in a Resource-Deprived Setting: A Cohort StudyPLOS Medicine, 2011
- A Simple Method for Principal Strata Effects When the Outcome Has Been Truncated Due to DeathAmerican Journal of Epidemiology, 2011
- Diagnosing and responding to violations in the positivity assumptionStatistical Methods in Medical Research, 2010
- A Targeted Maximum Likelihood Estimator of a Causal Effect on a Bounded Continuous OutcomeThe International Journal of Biostatistics, 2010
- An Application of Collaborative Targeted Maximum Likelihood Estimation in Causal Inference and GenomicsThe International Journal of Biostatistics, 2010
- Early Antiretroviral Therapy and Mortality among HIV-Infected InfantsNew England Journal of Medicine, 2008
- Estimating Optimal Transformations for Multiple Regression and CorrelationJournal of the American Statistical Association, 1985